Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,03200Cr 1.09TCr 972.53Cr 897.21Cr 815.15Cr 1.53TCr 1.55TCr 11TCr 4.26TCr 54TCr 4.09TCr 4TCr 1,71300Cr P/E 2027 *
28x
P/E 2028 * 21.5x
Enterprise Value 1,00000Cr 1.06TCr 942.42Cr 869.43Cr 789.91Cr 1.48TCr 1.5TCr 10TCr 4.13TCr 52TCr 3.96TCr 3.88TCr 1,66000Cr EV / Sales 2027 *
2.84x
EV / Sales 2028 * 2.49x
Free-Float
69.69%
Yield 2027 *
0.61%
Yield 2028 * 0.68%
1 day+0.30%
1 week+2.56%
Current month+4.83%
1 month+5.25%
3 months+16.26%
6 months+3.04%
Current year-5.77%
1 week 13.02
Extreme 13.015
13.35
1 month 11.99
Extreme 11.99
13.35
Current year 11.36
Extreme 11.36
15.67
1 year 11.36
Extreme 11.36
15.67
3 years 11.36
Extreme 11.36
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%+2.56% - - 1.09TCr
+2.83%+4.40%+60.84%+123.50% 1,16500Cr
+3.81%+5.66%+38.70%+74.91% 64TCr
+0.14%+0.63%+24.71%+95.03% 50TCr
-0.45%+3.06%+43.89%+64.51% 38TCr
-1.76%+1.41%+68.06%+43.41% 36TCr
-0.50%+2.95%+22.83%+51.93% 30TCr
-1.73%+2.64%+2.22%+26.48% 27TCr
+2.04%+3.05%+51.12%+60.42% 24TCr
+2.36%-0.11%+29.42%+102.04% 19TCr
Average -0.26%+2.54%+37.98%+71.36% 45.06TCr
Weighted average by Cap. -0.31%+3.17%+43.13%+83.13%

Financials

2027 *2028 *
Net sales 35TCr 371.36Cr 331.48Cr 305.81Cr 277.83Cr 521.21Cr 529.23Cr 3.68TCr 1.45TCr 18TCr 1.39TCr 1.36TCr 58TCr 39TCr 415.08Cr 370.5Cr 341.8Cr 310.54Cr 582.57Cr 591.53Cr 4.12TCr 1.62TCr 21TCr 1.56TCr 1.52TCr 65TCr
Net income 3.65TCr 39Cr 34Cr 32Cr 29Cr 54Cr 55Cr 382.59Cr 150.71Cr 1.91TCr 144.76Cr 141.66Cr 6.06TCr 4.86TCr 51Cr 46Cr 42Cr 38Cr 72Cr 73Cr 508.66Cr 200.37Cr 2.54TCr 192.47Cr 188.34Cr 8.06TCr
Net Debt -3.2TCr -34Cr -30Cr -28Cr -25Cr -47Cr -48Cr -334.68Cr -131.84Cr -1.67TCr -126.64Cr -123.92Cr -5.3TCr -5.14TCr -54Cr -48Cr -45Cr -41Cr -76Cr -77Cr -537.94Cr -211.91Cr -2.69TCr -203.54Cr -199.18Cr -8.53TCr
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
22/26/22 $13.23 +0.30% 39,83,257
21/26/21 $13.19 -0.53% 21,14,079
20/26/20 $13.26 +1.38% 42,33,449
19/26/19 $13.08 +0.08% 14,99,345
16/26/16 $13.07 +1.32% 27,94,066
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,239.00INR
Average target price
1,284.35INR
Spread / Average Target
+3.66%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Reddy's Laboratories Limited